DOT1L‐HES6 fusion drives androgen independent growth in prostate cancer. Issue 9 (8th July 2014) - Annala, Matti
Abstract Evidence is presented for a case of androgen receptor‐negative prostate cancer driven by a DOT1L‐HES6 fusion gene which directly induces overexpression and pathological activation of HES6.